Novartis Profit Beats Estimates, Signals Return to Growth
Earnings·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novartis AG reported higher-than-expected profit last quarter as newer cancer medicines offset the aging blockbuster Entresto’s generic hit, signaling a return to growth.
The results indicate a positive shift for the company as it navigates the challenges posed by generic competition.
Novartis
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Novartis AG reported higher-than-expected profit last quarter as newer cancer medicines offset the aging blockbuster Entresto’s generic hit, signaling a return to growth.”
Bloomberg — Novartis Profit Beats Estimates, Signals Return to Growth